Health & Life Co., Ltd.
Taipei ExchangeTotal Valuation
Health & Life Co., Ltd. carries a market capitalization of 568.89M, placing it among publicly traded companies globally. Its enterprise value stands at 471.78M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 568.89M |
| Enterprise Value | 471.78M |
Share Statistics
Health & Life Co., Ltd. currently has 47.41M shares outstanding.
| Shares Outstanding | 47.41M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Health & Life Co., Ltd. trades at a trailing price-to-earnings ratio of 35.91. The price-to-sales ratio is 1.31, and the price-to-book ratio stands at 1.61.
| PE Ratio | 35.91 |
| PS Ratio | 1.31 |
| PB Ratio | 1.61 |
| P/TBV Ratio | 1.64 |
| P/FCF Ratio | 50.70 |
| P/OCF Ratio | 164.18 |
Enterprise Valuation
On an enterprise value basis, Health & Life Co., Ltd. trades at an EV/EBITDA multiple of 820.38 and an EV/FCF ratio of 28.43. The EV/Sales ratio of 1.19 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 820.38 provides insight into valuation relative to core operating earnings.
| EV / Sales | 1.19 |
| EV / EBITDA | 820.38 |
| EV / EBIT | 820.38 |
| EV / FCF | 28.43 |
Financial Position
Health & Life Co., Ltd. maintains a current ratio of 2.39, meaning it holds 2.4x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 61.44, indicating elevated leverage, while an interest coverage ratio of -10.61 demonstrates limited ability to service its debt obligations.
| Current Ratio | 2.39 |
| Quick Ratio | 1.20 |
| Debt / Equity | 61.44 |
| Debt / EBITDA | -3.11 |
| Interest Coverage | -10.61 |
Financial Efficiency
| Return on Equity (ROE) | -17.36 |
| Return on Assets (ROA) | -8.01 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 2.63 |
Taxes
| Income Tax | -5.69M |
| Effective Tax Rate | N/A |
Stock Price Statistics
Health & Life Co., Ltd.'s stock has declined approximately -19.46309% over the past 52 weeks. The 50-day moving average sits at 11.32, while the 200-day moving average is 11.87.
| Beta (5Y) | N/A |
| 52-Week Price Change | -19.46309% |
| 50-Day Moving Average | 11.32 |
| 200-Day Moving Average | 11.87 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Health & Life Co., Ltd. generated 398.05M in revenue and converted that into -61.67M in net income, yielding earnings per share of -1.21. EBITDA reached -63.41M, while operating income came in at -63.41M.
| Revenue | 398.05M |
| Gross Profit | 70.12M |
| Operating Income | -63.41M |
| Pretax Income | -67.35M |
| Net Income | -61.67M |
| EBITDA | -63.41M |
| EBIT | -63.41M |
| Earnings Per Share (EPS) | -1.21 |
Balance Sheet
Health & Life Co., Ltd. holds 247.95M in cash and equivalents against 196.97M in total debt, resulting in a net debt position of -57.51M. Total book value stands at 324.23M, with working capital of 287.39M providing operational flexibility.
| Cash & Cash Equivalents | 247.95M |
| Total Debt | 196.97M |
| Net Debt | -57.51M |
| Equity (Book Value) | 324.23M |
| Book Value Per Share | 6.85 |
| Working Capital | 287.39M |
Cash Flow
Health & Life Co., Ltd. produced 3.18M in operating cash flow over the past twelve months. After subtracting -7.93M in capital expenditures, free cash flow totaled -4.75M - equivalent to -0.10 per share.
| Operating Cash Flow | 3.18M |
| Capital Expenditures | -7.93M |
| Free Cash Flow | -4.75M |
| FCF Per Share | -0.10 |
Margins
Health & Life Co., Ltd. operates with a gross margin of 17.62, reflecting its pricing power and cost economics. The operating margin of -15.93 and net profit margin of -15.49 provide insight into operational efficiency.
| Gross Margin | 17.62 |
| Operating Margin | -15.93 |
| Pretax Margin | -16.92 |
| Profit Margin | -15.49 |
| EBITDA Margin | -15.93 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | 4.19 |
| FCF Yield | 1.97 |
Stock Splits
Health & Life Co., Ltd.'s most recent stock split took place on September 14, 2006 with a 1000:1031 split ratio.
| Last Split Date | 9/14/2006 |
| Split Ratio | 1000:1031 |
Scores
Health & Life Co., Ltd. posts an Altman Z-Score of 1.23, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 1.23 |